VST BIO

VST BIO is a biotechnology company dedicated to developing antibodies for the treatment of inflammatory and cardiovascular diseases, including stroke, acute myocardial infarction, and sepsis. VST Bio utilizes this novel therapeutic agent to control inflammation and vascular permeability triggered by injury in acute stroke and other acute cardiovascular conditions (while managing edema formation), significantly expanding access to effective medical treatment for stroke patients—particularly the majority who do not seek medical attention within hours of symptom onset and are unable to receive standard conventional treatment.